Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Valproate Sodium | |
| Synonyms |
|
|
| Definitions |
The sodium salt form of valproic acid with anti-epileptic activity. Valproate sodium is converted into its active form, valproate ion, in blood. Although the mechanism of action remains to be elucidated, valproate sodium increases concentrations of gamma-aminobutyric acid (GABA) in the brain, probably due to inhibition of the enzymes responsible for the catabolism of GABA. This potentiates the synaptic actions of GABA. Valproate sodium may also affect potassium channels, thereby creating a direct membrane-stabilizing effect. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C48029 |
|
| CAS_Registry |
1069-66-5
|
|
| CHEBI_ID |
CHEBI:9925
|
|
| Chemical_Formula |
C8H15O2.Na
|
|
| code |
C48029
|
|
| Contributing_Source |
FDA
|
|
| definition |
The sodium salt form of valproic acid with anti-epileptic activity. Valproate sodium is converted into its active form, valproate ion, in blood. Although the mechanism of action remains to be elucidated, valproate sodium increases concentrations of gamma-aminobutyric acid (GABA) in the brain, probably due to inhibition of the enzymes responsible for the catabolism of GABA. This potentiates the synaptic actions of GABA. Valproate sodium may also affect potassium channels, thereby creating a direct membrane-stabilizing effect.
|
|
| FDA_UNII_Code |
5VOM6GYJ0D
|
|
| Has_Free_Acid_Or_Base_Form | ||
| in_subset | ||
| label |
Valproate Sodium
|
|
| Legacy Concept Name |
Valproate_Sodium
|
|
| Preferred_Name |
Valproate Sodium
|
|
| prefixIRI |
NCIT:C48029
|
|
| prefLabel |
Valproate Sodium
|
|
| Semantic_Type |
Pharmacologic Substance
|
|
| UMLS_CUI |
C0037567
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping